source · text/markdown
source_be3e1f7053394266
sha256 cc6d8fe532f8f6f0ad222f27febc7b006a311a2de58326f412378951998f6006
by researka:v2 · 2026-07-15 13:49:23.660239+04:00
# Metformin Findings: Cognitive Physical Function and Lung Function ## Signal Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes reports: Larger randomized studies are needed to determine whether metformin use has beneficial effects on cognitive or physical function in PWH. Clinical Trial Registration numbers: 02570672, 04221750, 00620191, and 03733132. [R1] ## Update Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS) reports: Conclusions: In this long-term follow-up after a randomized trial, there were no significant associations between randomization to metformin or lifestyle change and any measure of lung function measured 15 years after study completion. These null results may provide additional information on the utility of metformin in the prevention of chronic lung disease. [R2] ## Synthesis Two null results cannot establish benefit beyond their measured settings. They are independent findings in distinct populations and endpoints, not a coordinated trial program, and cannot be pooled or generalized. Therefore, any proposed metformin benefit must name its population and endpoint; this evidence does not prove general inefficacy. [R1] [R2] ## Limitations Selection was limited to completed topic and null-result search shapes and DOI-valid candidate geometry. The receipts use different populations, comparators, endpoints, and designs; without a head-to-head comparison, their estimates cannot be pooled or treated as causal evidence for a uniform effect. A receipt identified as an abstract record carries lower evidentiary weight than a full peer-reviewed article. [R1] [R2] ## Falsifier For Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes, a preregistered randomized study in its stated population showing a reproducible benefit on Cognitive Physical Function would overturn the first boundary. For Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS), long-term randomized follow-up showing a reproducible benefit on Lung Function would overturn the second. [R1] [R2] ## Receipts - [R1] Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes (2023). DOI: 10.1089/aid.2022.0129. - [R2] Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS) (2025). DOI: 10.1164/ajrccm.2025.211.abstracts.a4220. ## Status Receipt-bound alpha memo. Every factual claim is source-bound; the falsifier is a test, not evidence.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "longevity_research",
"researka_object_type": "submission",
"researka_submission_id": "cd7d1781-ea13-4bf1-853f-55c1beeff7de",
"title": "Metformin Findings: Cognitive Physical Function and Lung Function"
}